TherapeuticsMD, Inc. (TXMD) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 324 transactions totaling $122.7M, demonstrating a bearish sentiment with -$55.3M in net insider flow. The most recent transaction on Dec 23, 2025 involved a purchase of 8,400 shares valued at $14.0K.
No significant insider buying has been recorded for TXMD in the recent period.
No significant insider selling has been recorded for TXMD in the recent period.
Based on recent SEC filings, insider sentiment for TXMD is bearish with an Insider Alignment Score of 27/100 and a net flow of -$55.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at TherapeuticsMD, Inc. (TXMD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading TXMD stock, having executed 324 transactions in the past 90 days. The most active insider is Capital Management Lp Rubric (Executive), who has made 5 transactions totaling $91.4M.
Get notified when executives and directors at TXMD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | G. Thompson Tommy | Executive | Purchase | 8,400 | $1.67 | $14.0K | |
| Dec 23, 2025 | G. Thompson Tommy | Executive | Purchase | 8,400 | $1.67 | $14.0K | |
| Aug 22, 2024 | C. Collins Cooper | Executive | Purchase | 4,094 | $1.73 | $7.1K | |
| Aug 21, 2024 | C. Collins Cooper | Executive | Purchase | 1,200 | $1.70 | $2.0K | |
| Dec 7, 2023 | D. Walker Marlan | Executive | Sale | 4,550 | $2.24 | $10.2K | |
| Dec 6, 2023 | D. Walker Marlan | Executive | Sale | 14,500 | $2.31 | $33.5K | |
| Dec 5, 2023 | D. Walker Marlan | Executive | Option Exercise | 70,000 | $N/A | $0 | |
| Nov 15, 2023 | Efraim Rosen David | Executive | Award | 877,192 | $2.28 | $2.0M | Large |
| Aug 17, 2023 | Ziegler Joseph | Executive | Award | 7,500 | $N/A | $0 | |
| Jun 28, 2023 | Efraim Rosen David | Executive | Award | 312,525 | $3.68 | $1.2M | Large |
| Apr 26, 2023 | D. Walker Marlan | Executive | Sale | 692 | $3.64 | $2.5K | |
| Apr 26, 2023 | D. Walker Marlan | Executive | Option Exercise | 1,010 | $N/A | $0 | |
| Apr 26, 2023 | D. Walker Marlan | Executive | Option Exercise | 1,734 | $N/A | $0 | |
| Apr 12, 2023 | C. Donegan Michael | Executive | Option Exercise | 50,000 | $N/A | $0 | |
| Apr 12, 2023 | D. Walker Marlan | Executive | Option Exercise | 3,030 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 108 | $89.0M | 53.8% |
Disposition(D) | 1 | $38.7M | 23.4% |
Purchase(P) | 69 | $33.7M | 20.4% |
Award(A) | 3 | $3.2M | 1.9% |
Exercise(M) | 109 | $727.6K | 0.4% |
Exercise (Options)(X) | 3 | $111.1K | 0.1% |
Payment(F) | 2 | $87.5K | 0.1% |
Gift(G) | 27 | $0 | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Insider selling pressure at TherapeuticsMD, Inc. has increased, with 24 insiders executing 324 transactions across all time. Total sales of $89.0M significantly outpace purchases of $33.7M, resulting in a net outflow of $55.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.